Effects of Sitagliptin On Markers of Bone Turnover in Patients With Type 2 Diabetes.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2010
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 29 Jun 2010 Results from 9 patients were reported at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 25 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History